Target intelligence / Profile preview

Gastrointestinal proteases

Molecular classification
Enzyme, Hydrolase, Protease
01

Overview

Gastrointestinal proteases are a diverse group of enzymes responsible for the hydrolysis of dietary proteins into absorbable peptides and amino acids within the digestive tract. This group includes gastric enzymes like pepsin and pancreatic enzymes such as trypsin, chymotrypsin, elastase, and carboxypeptidases, as well as brush-border peptidases. Beyond their primary digestive role, these proteases act as signaling molecules by activating protease-activated receptors (PARs), which regulate intestinal permeability, inflammation, and visceral sensitivity. Dysregulation of proteolytic activity is a hallmark of several gastrointestinal disorders, including exocrine pancreatic insufficiency, inflammatory bowel disease (IBD), and irritable bowel syndrome (IBS). Therapeutically, these enzymes are targeted through replacement therapies (e.g., pancrelipase for pancreatic insufficiency) or through the use of inhibitors (e.g., camostat) to mitigate inflammation and pain. Additionally, exogenous proteases are being developed to detoxify gluten in patients with celiac disease.

Other names
Digestive proteasesIntestinal proteasesPancreatic proteasesGastric proteasesPeptidases
02

Mechanism of action

Hydrolysis of peptide bonds to facilitate protein digestion; activation of protease-activated receptors (PARs) to modulate intestinal signaling; degradation of immunogenic gluten peptides to prevent autoimmune responses.

03

Biological functions

DigestionSignal transductionImmune responseCell proliferationBarrier functionMicrobiome homeostasis
04

Disease associations

Exocrine pancreatic insufficiencyInflammatory bowel diseaseIrritable bowel syndromeCeliac diseaseColorectal cancerCystic fibrosis
05

Safety considerations

Gastrointestinal distress (bloating, diarrhea)Mucosal irritationImmunogenicity of exogenous enzymesPotential for malabsorption if over-inhibited
06

Interacting drugs

Pancrelipase

6 more in the full profile.

07

Biomarkers

Fecal elastase-1Fecal proteolytic activityMast cell tryptaseFecal chymotrypsin

Beyond the preview

Go deeper on Gastrointestinal proteases.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gastrointestinal proteases.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call